Stock Quote
Boston Scientific Corporation (BSX) (NYSE Arca)
$8.16
4:00pm EST
+0.87%
$8.09
$8.14
15,149,007
$8.23
$8.10
$11.77
$5.68
1.12
16,117,478
BSX
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Nicholas, Peter | Chairman of the Board | 1,265,810 |
| Elliott, Ray | President, Chief Executive Officer | -- |
| Leno, Sam | Chief Financial Officer, Executive Vice President - Finance and Information Systems | 6,321,260 |
Profile
Boston Scientific Corporation is a developer, manufacturer, and marketer of medical devices that are used in a broad range of interventional medical specialties, including cardiology, cardiac rhythm management, peripheral interventions, electrophysiology, neurovascular intervention, endoscopy,... Full Description
Company Address
Boston Scientific Corporation
One Boston Scientific Place
Natick MA 01760
P: +1508.6508000
F: +1508.6508923
One Boston Scientific Place
Natick MA 01760
P: +1508.6508000
F: +1508.6508923
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Johnson & Johnson | $62.69 | +0.38 |
| Medtronic, Inc. | $40.31 | +0.69 |
| Abbott Laboratories | $53.13 | -0.51 |
| BSX | Industry | |
|---|---|---|
| P/E(TTM) | -- | 7.62 |
| P/S(TTM) | 1.51 | 0.46 |
| ROI(TTM) | -9.64 | 0.98 |
| ROE(TTM) | -16.41 | 1.52 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | 0.14 |
| EPS Est. (Current Year) | 0.53 |
| Total Revenue | $2,025.00M |
| Net Income | $-94.00M |
| EPS | $-0.06 |
